Grifols, S.A. (GRFS)
NASDAQ: GRFS · Real-Time Price · USD
9.92
+0.05 (0.51%)
Aug 29, 2025, 2:55 PM - Market open
Grifols Market Cap
Grifols has a market cap or net worth of $8.62 billion as of August 29, 2025. Its market cap has increased by 82.00% in one year.
Market Cap
8.62B
Enterprise Value
22.02B
1-Year Change
82.00%
Ranking
Category
Stock Price
$9.92
Market Cap Chart
Since June 2, 2011, Grifols's market cap has increased from $5.00B to $8.62B, an increase of 72.56%. That is a compound annual growth rate of 3.90%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 28, 2025 | 6.79B | 32.66% |
Dec 31, 2024 | 5.12B | -35.64% |
Dec 29, 2023 | 7.95B | 36.00% |
Dec 30, 2022 | 5.84B | -24.31% |
Dec 31, 2021 | 7.72B | -39.10% |
Dec 31, 2020 | 12.68B | -20.82% |
Dec 31, 2019 | 16.01B | 26.85% |
Dec 31, 2018 | 12.62B | -19.90% |
Dec 29, 2017 | 15.76B | 42.63% |
Dec 30, 2016 | 11.05B | -0.80% |
Dec 31, 2015 | 11.14B | -4.68% |
Dec 31, 2014 | 11.69B | -0.94% |
Dec 31, 2013 | 11.80B | 39.30% |
Dec 31, 2012 | 8.47B | 134.45% |
Dec 30, 2011 | 3.61B | -27.71% |
Jun 2, 2011 | 5.00B | - |
View and export this data all the way back to 2011. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 659.00B |
Johnson & Johnson | 424.64B |
AbbVie | 369.62B |
UnitedHealth Group | 275.51B |
Novo Nordisk | 249.15B |
AstraZeneca | 247.41B |
Novartis AG | 245.07B |
Abbott Laboratories | 229.20B |